Observational suspected adverse drug reaction profiles of fluoro-pharmaceuticals and potential mimicry of per- and polyfluoroalkyl substances (PFAS) in the United Kingdom. [PDF]
Balasubramaniam B, Jones AM.
europepmc +1 more source
Effects of lansoprazole, clarithromycin and pH gradient on uptake of [14C]amoxycillin into rat gastric tissue [PDF]
H. Endo
openalex +1 more source
Evaluating the cost-effectiveness of replacing lansoprazole with vonoprazan for treating erosive oesophagitis. [PDF]
Jeyarajan S +6 more
europepmc +1 more source
Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis [PDF]
Christophe Fauré +8 more
openalex +1 more source
Pharmacodynamics, pharmacokinetics, interactions with other drugs, toxicity and clinical effectiveness of proton pump inhibitors. [PDF]
Wołowiec Ł +7 more
europepmc +1 more source
Long‐term lansoprazole control of gastric acid and pepsin secretion in ZE and non‐ZE hypersecretors: a prospective 10‐year study [PDF]
Basil I. Hirschowitz +2 more
openalex +1 more source
Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay. [PDF]
Priyadharshini A +4 more
europepmc +1 more source
A Prospective Trial of Lansoprazole Triple Therapy for Pediatric Helicobacter pylori Infection
Harohalli Shashidhar +5 more
openalex +1 more source

